Concepedia

Anna Milton

AM

Statistics

Publications

5

Citations

172

H-Index

5

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Anna Milton is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, radiation oncology, and cancer research.

ORCID

Top concepts

Publications per year

2020–2022

5

Publications

5

Morc3 silences endogenous retroviruses by enabling Daxx-mediated histone H3.3 incorporation

Sophia Groh, Anna Milton, Lisa Marinelli et al. · Nature Communications · 2021 · 53 citations · Full text

Updated Results from a Phase I/II Study of the Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia

Nicholas J. Short, Courtney D. DiNardo, Naval Daver et al. · Blood · 2022 · 38 citations

, , +9

A Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia: Results from a Phase I/II Study

Nicholas J. Short, Courtney D. DiNardo, Naval Daver et al. · Blood · 2021 · 36 citations

Updated Results of a Phase II Study of Ponatinib and Blinatumomab for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Nicholas J. Short, Hagop M. Kantarjian, Marina Konopleva et al. · Blood · 2021 · 26 citations

Reduced-Intensity Chemotherapy with Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study

Nicholas J. Short, Hagop M. Kantarjian, Farhad Ravandi et al. · Blood · 2020 · 19 citations

1–5 of 5